Chemoresistance in Breast Cancer Patients Associated With Changes in P2X7 and A2A Purinergic Receptors in CD8(+) T Lymphocytes

Breast cancer (BRCA) is the most frequent cancer type that afflicts women. Unfortunately, despite all the current therapeutic strategies, many patients develop chemoresistance hampering the efficacy of treatment. Hence, an early indicator of therapy efficacy might aid in the search for better treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz-Rodríguez, Victor Manuel, Turiján-Espinoza, Eneida, Guel-Pañola, Jaime Arturo, García-Hernández, Mariana Haydee, Zermeño-Nava, José de Jesús, López-López, Nallely, Bernal-Silva, Sofia, Layseca-Espinosa, Esther, Fuentes-Pananá, Ezequiel M., Estrada-Sánchez, Ana María, Portales-Pérez, Diana Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750810/
https://www.ncbi.nlm.nih.gov/pubmed/33364951
http://dx.doi.org/10.3389/fphar.2020.576955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750810/
https://www.ncbi.nlm.nih.gov/pubmed/33364951
http://dx.doi.org/10.3389/fphar.2020.576955

Ejemplares similares